Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Vera Therapeutics, Inc.CL A(VERA) | 600,836 | 808,717 | +207,881 | $25.78M | $26.11M | 6.85% | +$331.6K |
| Vor Biopharma Inc.(VOR) | 1,700,000 | 1,126,910 | -573,090 | $31.30M | $21.50M | 5.64% | -$9.80M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 700,000 | 700,000 | 0 | $12.57M | $20.37M | 5.35% | +$7.80M |
| Sagimet Biosciences IncCOM SER A | 2,029,933 | 1,961,701 | -68,232 | $15.69M | $19.38M | 5.09% | +$3.69M |
| Definium Therapeutics, Inc.(DFTX) | 425,000 | 508,735 | +83,735 | $19.99M | $19.36M | 5.08% | -$629.5K |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 420,000 | +420,000 | $0 | $18.75M | 4.92% | +$18.75M |
| Genmab A/SADS(GMAB) | 0 | 525,000 | +525,000 | $0 | $18.73M | 4.92% | +$18.73M |
| Sol-Gel Technologies LtdSHS NEW SHS NEW | 274,363 | 239,159 | -35,204 | $20.34M | $17.76M | 4.66% | -$2.58M |
| Zura Bio LtdCL A | 4,215,930 | 4,077,256 | -138,674 | $24.87M | $16.96M | 4.45% | -$7.91M |
| LB Pharmaceuticals Inc(LBRX) | 317,221 | 410,420 | +93,199 | $10.30M | $15.75M | 4.13% | +$5.46M |
| ABIVAX Société AnonymeADS(ABVX) | 204,314 | 155,000 | -49,314 | $27.23M | $15.35M | 4.03% | -$11.88M |
| Annexon Inc | 3,500,000 | 3,500,000 | 0 | $19.98M | $14.80M | 3.89% | -$5.18M |
| Belite Bio, IncADS(BLTE) | 0 | 75,000 | +75,000 | $0 | $12.74M | 3.34% | +$12.74M |
| Eupraxia Pharmaceuticals Inc | 1,200,000 | 1,200,000 | 0 | $7.93M | $10.92M | 2.87% | +$2.99M |
| Nektar Therapeutics(NKTR) | 175,000 | 175,000 | 0 | $12.22M | $10.60M | 2.78% | -$1.62M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 855,813 | 855,813 | 0 | $16.66M | $10.01M | 2.63% | -$6.65M |
| Climb Bio Inc | 1,000,000 | 800,000 | -200,000 | $13.04M | $9.18M | 2.41% | -$3.86M |
| AbCellera Biologics Inc.(ABCL) | 0 | 600,000 | +600,000 | $0 | $8.75M | 2.30% | +$8.75M |
| Neurogene Inc | 352,180 | 300,000 | -52,180 | $11.08M | $8.35M | 2.19% | -$2.73M |
| COMPASS Pathways plcADS(CMPS) | 0 | 500,000 | +500,000 | $0 | $6.22M | 1.63% | +$6.22M |
| Jatt Ii Acquisition Corp | 500,000 | 500,000 | 0 | $5.68M | $5.62M | 1.48% | -$57.5K |
| Inflarx Nv | 3,046,557 | 3,046,557 | 0 | $6.82M | $5.48M | 1.44% | -$1.34M |
| Research Alliance Corp IiiCL A | 0 | 504,891 | +504,891 | $0 | $5.47M | 1.44% | +$5.47M |
| Bright Minds Biosciences Inc | 109,603 | 109,603 | 0 | $7.69M | $5.46M | 1.43% | -$2.23M |
| Amanat Acquisition CorpCL A | 500,000 | 500,000 | 0 | $5.08M | $5.34M | 1.40% | +$260.0K |
| Altimmune Inc | 1,741,232 | 1,741,232 | 0 | $5.29M | $4.98M | 1.31% | -$313.4K |
| Jatt Iii Acquisition Corp | 0 | 450,000 | +450,000 | $0 | $4.96M | 1.30% | +$4.96M |
| Scynexis Inc | 944,292 | 944,292 | 0 | $3.84M | $4.66M | 1.22% | +$821.5K |
| Cullinan Therapeutics Inc | 300,000 | 300,000 | 0 | $5.46M | $4.61M | 1.21% | -$858.0K |
| Cybin Inc | 0 | 320,952 | +320,952 | $0 | $3.94M | 1.04% | +$3.94M |
| Rezolute Inc | 951,809 | 951,809 | 0 | $4.95M | $3.94M | 1.03% | -$1.01M |
| Opus Genetics Inc | 1,970,187 | 776,881 | -1,193,306 | $8.10M | $3.76M | 0.99% | -$4.34M |
| Enliven Therapeutics Inc | 70,000 | 70,000 | 0 | $3.55M | $3.21M | 0.84% | -$343.7K |
| Relmada Therapeutics Inc | 842,106 | 842,106 | 0 | $5.83M | $3.17M | 0.83% | -$2.65M |
| Dbv Technologies S AADS | 156,906 | 250,000 | +93,094 | $2.57M | $2.94M | 0.77% | +$366.7K |
| Evommune Inc | 325,000 | 325,000 | 0 | $4.32M | $2.68M | 0.70% | -$1.63M |
| Contineum Therapeutics IncCL A | 921,481 | 186,183 | -735,298 | $15.10M | $2.50M | 0.66% | -$12.60M |
| Oruka Therapeutics, Inc.(ORKA) | 183,330 | 24,649 | -158,681 | $17.45M | $2.05M | 0.54% | -$15.39M |
| Humacyte Inc | 3,750,000 | 3,750,000 | 0 | $2.93M | $1.94M | 0.51% | -$985.1K |
| Rein Therapeutics Inc | 2,575,000 | 1,663,144 | -911,856 | $2.68M | $1.34M | 0.35% | -$1.34M |
| Research Alliance Corp IvCL A | 0 | 106,396 | +106,396 | $0 | $1.28M | 0.34% | +$1.28M |
| Alumis Inc | 856,061 | 0 | -856,061 | $24.09M | $0 | — | -$24.09M |
| Immix Biopharma, Inc.(IMMX) | 1,277,642 | 0 | -1,277,642 | $13.17M | $0 | — | -$13.17M |
| Palisade Bio, Inc.(PALI) | 2,284,819 | 0 | -2,284,819 | $4.78M | $0 | — | -$4.78M |
| ProMIS Neurosciences, Inc.(PMN) | 86,150 | 0 | -86,150 | $1.13M | $0 | — | -$1.13M |
| Silence Therapeutics plcADS(SLN) | 450,000 | 0 | -450,000 | $4.94M | $0 | — | -$4.94M |